Pune: Serum Institute of India CEO Adar Poonawalla is expecting approval for COVID-19 vaccine by end of December, while the vaccination drive in the country could start by next month.…
New Delhi: Union Health Minister Harsh Vardhan said that late-stage clinical trials of intranasal COVID-19 vaccines are expected to be pursued by Serum Institute of India and Bharat Biotech…
New Delhi: With pharma giant AstraZeneca pausing the Oxford COVID-19 vaccine candidate's trials in other countries, the Serum Institute of India (SII) has been suspended by the Drugs…
The clinical trials of the COVID-19 vaccine candidate being developed by Oxford University and AstraZeneca may have been put on pause following an adverse reaction observed in one of the…
New Delhi: An expert committee at the apex drug regulator, Central Drugs Standards Control Organisation (CDSCO) has deferred its earlier call on Serum Institute of India Pvt Ltd’s vaccine…
New Delhi: The Drug Controller General of India (DCGI) on Wednesday approved the first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine developed by Serum Institute…
New Delhi: The Department of Biotechnology (DBT) will provide funds to three companies, Cadila Healthcare Ltd (Zydus Cadila), Bharat Biotech International Ltd and Serum Institute of India…